Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05530759

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

Sponsor: Mayo Clinic

View on ClinicalTrials.gov

Summary

This study characterizes deoxyribonucleic acid (DNA) and proteomic (protein) changes in both biopsies and tumors removed during surgery of patients who have been diagnosed with aggressive/metastatic (that has spread to other places in the body) cancer in order to identify possible diagnostic markers and potential drugs for treating aggressive tumor types. Proteomic analyses include looking at the proteome, or all the proteins expressed, or made by DNA at a specific moment in time. Studying samples of blood, buccal (cheek), and tissue in the laboratory from patients undergoing surgical resection or biopsy may help doctors learn more about the changes that occur in the proteome, DNA alterations, and identify molecular biomarkers for which therapeutic drugs may exist. Studying the DNA in tumor tissue and in blood may also help researchers see if the tumor has important differences.

Official title: Integrated Genomics and Patient-Derived Cancer Models

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

OBSERVATIONAL

Enrollment

50

Start Date

2022-06-29

Completion Date

2028-04-07

Last Updated

2025-04-02

Healthy Volunteers

No

Interventions

PROCEDURE

Biopsy Specimen

Undergo collection of tissue samples

PROCEDURE

Biospecimen Collection

Undergo collection of blood and buccal swab samples

PROCEDURE

Biospecimen Collection

Undergo collection of archived tissue and blood samples

OTHER

Medical Chart Review

Review of medical record

Locations (1)

Mayo Clinic in Rochester

Rochester, Minnesota, United States